Enovid/NOWONDER™ is a nasal spray designed to prevent infection from viruses, including all current versions of the SARS-CoV-2 virus, by reducing the viral load within the respiratory tract. It delivers a measured dose of nitric oxide in each use. Phase 3 clinical trials showed that viral replication was suppressed within 24 hours of treatment. NOWONDER™ is now classified as a cosmetic product with no expiration date but a Period After Opening (PAO) label. This indicates the product should be discarded 6 months after opening to ensure safety and effectiveness.

Click here for the Enovid/NOWONDER User Guide. 

Enovid/NOWONDER™s Nitric Oxide Nasal Spray (NONS) is a proprietary drug preparation from SaNOtize. It was designed to kill viruses, such as the one that causes COVID-19, in the upper airways, preventing them from incubating and spreading to the lungs. In trials, it was shown to reduce the viral load in COVID-19 patients by more than 95%.

Subsequent controlled studies of later SARS-CoV-2 virus variants show a reduction in viral load within 24 hours of treatment with NONS. NONS delivers a broad-spectrum antiviral that is effective in the lab against various viruses, including SARS-CoV-2, influenza, and respiratory syncytial viruses. Despite the frequency of virus mutations, this has not interfered with its effectiveness against viral replication.

Each bottle contains a month’s supply for one person to spray twice daily to protect against viruses.

How Enovid/NOWONDER™ Works

Enovid/NOWONDER™ is like a “hand sanitizer for the nose.” It delivers a “chemical barrier” of nitric oxide, which creates a physical barrier in the nasal passages to stop viruses from invading the linings and is known for its antimicrobial qualities.

SaNOtize’s proprietary technology creates a measured amount of nitric oxide only when used. Nitric oxide is not a component of the spray.

When to use Enovid/NOWONDER™?

Enovid/NOWONDER™ shields against respiratory viruses and should be administered before possible exposure to other infected people, such as on public transportation, in health care settings, daycares, shopping centers, sports events, etc. It can also be used shortly after suspected virus exposure, especially by individuals with other health conditions. 

Dosage

Enovid/NOWONDER™ may be applied 2-3 times daily and up to 6 times on any day when there could be or was close exposure to people carrying the viruses. This is especially the case if coming into contact with virus-infected people who have traveled to countries with high levels of infection. People at special risk, such as pregnant women, aged people, and people with compromised immune systems, can also safely use Enovid/NOWONDER™ at higher dosages.

Enovid/NOWONDER™ can be used by teenagers aged 12 and over, and adults.

Storage

The spray can be used for six months after the first opening. The inhaler should be kept with the cap on, and at temperatures below 25ºC/77ºF